<sup>18</sup>F-FDG Avidity of Pheochromocytomas and Paragangliomas: A New Molecular Imaging Signature?David Taïeb, O. Mundler, F. Sébag et al.|Journal of Nuclear Medicine|2009Cited by 126
Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours?Laurent Tessonnier, David Taïeb, C. Colavolpe et al.|European Journal of Nuclear Medicine and Molecular Imaging|2008Cited by 100
18F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinomaAurélien Archier, David Taïeb, C. Heimburger et al.|European Journal of Nuclear Medicine and Molecular Imaging|2015Cited by 56
Comparison of [<sup>111</sup>In]pentetreotide‐SPECT and [<sup>18</sup>F]FDOPA‐PET in the localization of extra‐adrenal paragangliomas: the case for a patient‐tailored use of nuclear imaging modalitiesNathalie Charrier, David Taïeb, Arnaud Devèze et al.|Clinical Endocrinology|2010Cited by 42
Heath-related quality of life in thyroid cancer patients following radioiodine ablationDavid Taïeb, O. Mundler, Karine Baumstarck et al.|Health and Quality of Life Outcomes|2011Cited by 39